Beili Zhang

This inventor holds 33 USPTO granted patents and 21 published patent applications, plus 7 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Vertex Pharmaceuticals, Inc., Gb002, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beili Zhang. Retrieved from https://idiyas.com/inventor/beili-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 21)

% Patents Active = 97.0

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 4.8

ph-index = 21

Forward Citations = 1,243(Granted Patents)

Company Filing History:

32 out of 1,167

Vertex Pharmaceuticals, Inc.

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

CFTR Modulators

Pharmaceutical Compositions

Solid Forms

Prodrugs

Sodium Channels

Crystalline Forms

Pyridone Amides

Cyclopropanecarboxamide

Benzoic Acid

Trifluoromethyl

Dihydroquinoline

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703693 - Crystalline forms of N-{3-[(1S)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methods (2026-08-11),

2. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),

3. 12065432 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2024-08-20),

4. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),

5. 11773119 - Prodrugs of pyridone amides useful as modulators of sodium channels (2023-10-03),

6. 11578062 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2023-02-14),

7. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2021-11-30),

8. 11155533 - Crystalline forms and compositions of CFTR modulators (2021-10-26),

9. 10906891 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2021-02-02),

10. 10787472 - Prodrugs of pyridone amides useful as modulators of sodium channels (2020-09-29),

11. 10654829 - Crystalline forms and compositions of CFTR modulators (2020-05-19),

12. 10597384 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2020-03-24),

13. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2020-02-25),

14. 10253054 - Prodrugs of pyridone amides useful as modulators of sodium channels (2019-04-09),

15. 10081621 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2018-09-25),

Title: Beili Zhang: Innovator in Pharmaceutical Science

Introduction

Beili Zhang is a prolific inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical science. With an impressive portfolio of 31 patents, Zhang has made remarkable strides in developing innovative treatments that enhance the quality of life for patients with various medical conditions.

Latest Patents

Zhang's latest patents reflect his expertise and innovative spirit. One of his notable inventions is a solid form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid. This invention involves a substantially crystalline and free solid-state form (Form I) which, along with its pharmaceutical compositions, offers potential methods of treatment. Additionally, his work on crystalline forms of CFTR modulators introduces new pharmaceutical compositions along with methods to treat cystic fibrosis, showcasing his dedication to addressing complex health challenges.

Career Highlights

Throughout his career, Beili Zhang has been associated with renowned companies, including Vertex Pharmaceuticals. His innovative research and patented technologies have contributed to the advancement of pharmaceutical therapeutics. Through his work, he has significantly impacted the landscape of drug development, paving the way for novel treatments.

Collaborations

Zhang has collaborated with several notable professionals in the industry, including Ali Keshavarz-Shokri and Mariusz Krawiec. These collaborations have fostered a rich environment for innovation and have led to the successful development of groundbreaking pharmaceutical applications.

Conclusion

Beili Zhang stands out as a leader in pharmaceutical innovation. His extensive patent portfolio and commitment to research highlight his role in advancing medical science, particularly in the development of treatments for serious health conditions. As he continues to innovate, Zhang's contributions to the field will undoubtedly continue to benefit patients and the medical community alike.

Profile summary based on public USPTO records.